Loading...
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
Koessler, T. Alsina, M. Arnold, D. Ben-Aharon, I. Lutz, M. P. Obermannova, R. Peeters, M. Sclafani, F. Smyth, E.
Koessler, T.
Alsina, M.
Arnold, D.
Ben-Aharon, I.
Lutz, M. P.
Obermannova, R.
Peeters, M.
Sclafani, F.
Smyth, E.
Citations
Altmetric:
Abstract
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial results have been reported, some leading to a change of practice. Furthermore, during ASCO-GI 2021, results from early phase trials have been presented, some with potential important implications for future treatments. We provide here an overview of these important results and their integration into routine clinical practice
Description
Date
2021
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 992.02 KB
Keywords
Type
Article
Citation
Koessler T, Alsina M, Arnold D, Ben-Aharon I, Lutz MP, Obermannova R, et al. Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group. Br J Cancer. 2021 Aug 23.